P&T Perspectives
Real P&T Professionals. Real Market Research.
- Predict P&T Committee Decisions and Competitive Positioning: Forecast how P&T committees may evaluate your drug against competitors to inform market access strategy.
- Understand Pricing Impact on Formulary Placement: Analyze how drug pricing and contracting strategies influence formulary positioning, tier status, and coverage decisions.
- Identify Potential Coverage Restrictions: Anticipate payer restrictions—such as prior authorization and step therapy—for your therapy and competing products.
- Improve Launch Strategy: Optimize your drug’s launch trajectory by identifying the most competitive contracting scenarios.
Gain Insights from Real P&T Professionals
What Our Clients Are Saying
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
How We Can Help
MMIT’s industry-leading P&T panel is composed of pharmacy decision-makers from health plans, pharmacy benefit managers (PBMs), providers, and integrated delivery systems (IDNs). With 100% of panelists actively participating in P&T committees or directly controlling pharmaceutical access within their organizations, MMIT delivers unparalleled visibility into payer decision-making, formulary access, and market access strategy.
P&T Perspectives enables your team to forecast how real P&T committee members will evaluate your drug by simulating an authentic review that reveals competitive positioning and payer decision‑making dynamics.
P&T Perspectives provides direct insight into how pricing and clinical value influence formulary placement by showing how pharmacy and medical decision‑makers assess financial impact and therapeutic differentiation.
P&T Perspectives helps you anticipate likely coverage restrictions—such as prior authorization, step therapy, and contracting requirements—by identifying the controls P&T stakeholders would apply during a simulated committee review.
Key Insights From MMIT
Improving Access with Market Research Insights
In this ebook, see how nine different manufacturers have partnered with MMIT on qualitative and quantitative custom market research.
Strategies for Early Market Access Planning
This webinar details how and why manufacturers benefit from early market research, using client use cases to show how planning for potential access scenarios leads to greater utilization at launch.
Preparing for Launch with P&T Perspectives
Learn how a P&T review helped one pharma company understand how its product would be assessed, leading to a new focus on gathering real-world evidence.
Solutions to Support Your Strategy
Strengthen P&T Perspectives by leveraging complementary solutions that deliver comprehensive insights into market dynamics, payer messaging, real-time stakeholder feedback, and strategic launch planning. These offerings empower your team to translate intelligence into decisive, well-informed strategies.
Message Monitor
Use Message Monitor to capture key payer and IDN decision-makers’ insights around brand perception so you can better position your product against the competition.
Analytics
As the leading platform for pharma market access teams, MMIT Analytics analyzes comprehensive formulary, policy and restriction information to evaluate patient access for your brands, competitors and analogs.
Rapid Response
Improve your brand strategy with Rapid Response’s quick, actionable answers to key business questions among a representative sample of the payer and IDN stakeholders that you care about.
Strategic Launch Report and Evaluate Forecast
MMIT launch reports help manufacturers vet potential analog products, outline payer and channel segmentation, and highlight potential restrictions to drug launch policies, speeding up commercialization.